Madeleine Johnson

The new assay makes a number of modifications to enhance the sensitivity of the CRISPR reaction and allow detection of rare targets.

Branded InSignia, the patented technology will first be incorporated into a gonorrhea antimicrobial susceptibility assay, followed by a point-of-care test.

The Charlottesville, Virginia-based company expects to add an infectious disease test menu to its system using its proprietary extraction process.

The WHO and US CDC emphasized a need for increased testing and test development at separate events last week.

The Park City, Utah-based firm combines RT-LAMP with lyophilization and a scalable manufacturing system for its laminate card technology that keeps costs low.

The firm expects to establish a US-based development and manufacturing footprint for its multiplex PCR assay kits.

The firm submitted a low-cost RT-LAMP device and COVID test to the FDA for Emergency Use Authorization this week.

Molecular diagnostics revenue dropped 47 percent due to lower volumes and selling prices for COVID-19 PCR products.

The firm provided updates on its business while it undergoes an internal strategic review process aimed at enhancing shareholder value.

A team in South Korea has developed a method that can increase sensitivity when paired with surface-enhanced Raman spectroscopy.